News
4P-Pharma at Biofit 2017
4P-Pharma Business Development Team will be attending the upcoming Biofit 2017 conference in Strasbourg on November 28-29th. To learn more about possible partnerships, co-development and our services, contact us via the partnering platform or at contact (at)4p-pharma.com. Looking forward to meet you there!
BigBooster competition: 4P-Pharma among Top50 selected startups to enter the BoosterHub
4P-Pharma is among the Top50 startups, coming from 4 continents, to enter the BoosterHub of the BigBooster accelerator program. Big Booster, an international non-profit acceleration program for startups held its EU BoosterCamp in Lyon on november 14-16th. The three day workshop was punctuated by a pitch contest to select the Top50 startups, out of a&hellip
4 P-Pharma among the Top 100 startups selected for BigBooster 3rd edition
We are pleased to announce that 4P-Pharma is among the Top 100 start-ups selected to participate in the 3rd edition of Big Booster, an international non-profit acceleration program for startups. We are looking forward to meet all the Big Booster actors at the Lyon Booster Camp November 14th-16th. During this event we will be presenting&hellip
4P-Pharma at BPI Innogeneration
Our BD team will attend the next BPI Innogeneration on thursday october 12th. If you would like to discuss about potential collaboration and early-stage technologies in the field of oncology and inflammation, do not hesitate to contact us: contact at 4p-pharma.com See you there!
4P-Pharma an actor in ADHD pipeline drug development
4P-Pharma is a recognized actor in the ADHD pipeline drug development. Stimulant abuse and addiction is a major global health problem and prescription drugs are indeed more and more abused, in virtue of their “rewarding” psychotropic effects. ADHD medications abuse increased by 4 fold, and led to a 400% increased in emergency room visits from&hellip